Global Neurology Leaders to Support Development of a Potentially Restorative Treatment for MS as Program Advances Toward 2023 Regulatory Filing Company also Expands Regenerative Medicine Advisory ...

BUFFALO, N.Y. — Two papers by University at Buffalo researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to ...

Two papers by UB researchers reveal important new findings as to how regeneration of myelin in multiple sclerosis fails and, potentially, more efficient ways to treat it. The findings include the ...

The differentiation of oligodendrocyte progenitor cells (OPCs) into oligodendrocytes (OLs) promotes the remyelination in human brain. In multiple sclerosis (MS), dysfunctional OPC differentiation ...

Multiple sclerosis (MS) involves the progressive loss of the protective layer of nerve fibers, myelin, and its loss, called demyelination, results in symptoms of MS. Blocking the protein receptor, ...

Ari Green, MD, of the University of California, San Francisco, details the benefits of remyelination for patients with multiple sclerosis (MS), as well as the challenges faced when conducting ...

PARIS — A monoclonal antibody directed against a human retroviral protein thought to play a role in the multiple sclerosis (MS) disease process did not show a significant effect on the primary ...

The therapeutic landscape for multiple sclerosis (MS) is evolving beyond modulating the peripheral immune response. New strategies are now focussed on reducing inflammation and promoting the ...

Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the brain and spinal cord. In MS, aberrant immune cells mistakenly target and strip myelin away from nerve fibres. Nerve ...

Rob Etherington drives an electric car with a personalized license plate that reads “CLENE,” as in Clene Nanomedicine, the company he leads as President and CEO: “Many people ask me, is it because ...